Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial - Lexis, Chris P. H.; van der Horst, Iwan C. C.; Lipsic, Erik; van der Harst, Pim; van der Horst-Schrivers, Anouk N. A.; Wolffenbuttel, Bruce H. R.; de Boer, Rudolf A.; van Rossum, Albert C.; van Veldhuisen, Dirk J.; de Smet, Bart J. G. L. (Cardiovascular drugs and therapy, 2012)
Keywords: Biological and medical sciences; Cardiology; Cardiology. Vascular system; Cardiovascular system; Coronary heart disease; Diabetes. Impaired glucose tolerance; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Glucose Tolerance Test; Heart; Heart failure, cardiogenic pulmonary edema, cardiac enlargement; Humans; Hypoglycemic Agents - therapeutic use; Medical sciences; Medicine; Medicine & Public Health; Metformin - therapeutic use; Myocardial Infarction - drug therapy; Myocardial Infarction - surgery; Percutaneous Coronary Intervention; Pharmacology. Drug treatments; Ventricular Dysfunction, Left - drug therapy; Ventricular Dysfunction, Left - surgery; Ventricular Function, Left - drug effects; Ventricular Function, Left - physiology; Heart failure; ST-elevation myocardial infarction; Metformin; Cardiac remodeling; Left ventricular ejection fraction; Endocrinopathy; Heart; Human; Myocardial infarction; Diabetes mellitus; Cardiovascular disease; Patient; Coronary heart disease; Myocardial disease; Left ventricle; Percutaneous route; ST elevation; Hypoglycemic agent; Biguanides; Gastrointestinal hormone; Circulatory system; Gastric inhibitory peptide; Ejection fraction